Inactive

**Please see the attached request for quotation (RFQ) document for full details.** BACKGROUND The National Cancer Institute (NCI), Center for Cancer Research (CCR), Oncogenomic Section is currently de... **Please see the attached request for quotation (RFQ) document for full details.** BACKGROUND The National Cancer Institute (NCI), Center for Cancer Research (CCR), Oncogenomic Section is currently developing novel therapies for pediatric cancers through different approaches including CRISPR-based genetic screen, drug screen, antibody-based and adaptive cell-based therapeutics. These approaches rely on continuous cell growth monitoring. The CCR has used the IncuCyte Zoom HD/2CLR system monitoring of cells since 2013, and it has become a standard routine cell assay to characterize cancer cells in various experimental conditions. Support of this system is being discontinued at the end of 2021. Thus, CCR seeks to procure a new brand-name or equal IncuCyte S3 Live-cell analysis system to continue its research. This instrument will ensure on-going projects continue uninterrupted and that future data will be compatible with the existing data. SUBMISSION INSTRUCTIONS This Request for Quotation (RFQ) does not commit the Government to pay any cost for preparation and submission of a quote. In addition, the Contracting Officer is the only individual who can legally commit the Government to the expenditure of public funds in connection with this proposed acquisition. By submitting a quote in response to this solicitation, it is understood that your firm’s quote shall become a part of the official contract file. The Government reserves the right to request revisions that seek additional price discounts revisions to the technical quote, or clarifications for aspects of the quote. In the event that the Government seeks revisions or clarifications, the Contract Specialist will provide a reasonable deadline for submission of those revisions/clarifications based on the complexity of the request. The Government reserves the right to request revisions or clarifications from only one or a select number of Quoters, if doing so would be in the public interests. Due to the current COVID-19 pandemic, all Quoters must pay close attention to the following delivery instructions and ensure that sufficient information is included in the quote in order to be considered for an award. Please be aware that due to the fluidity of the existing pandemic, instructions may be updated as needed after award. By submitting a quote, the Contractor agrees: The equipment will be stored or held equipment at no additional cost, if a delay is caused due to conditions related to the COVID-19 pandemic. The equipment will not be sold to another company in the event NCI is not ready to accept delivery due to unanticipated changes related to COVID-19. Training as required by the Statement of Need will be made available and provided to required staff, if applicable, at no additional cost if a delay is caused due to conditions related to the COVID-19 pandemic. The items outlined in the Statement of Need (SON) are available and can be delivered by the due date specified in the order. QUOTATIONS Quotations must be submitted electronically via e-mail to the Contract Specialist, Renee Jones-Chuang, at renee.jones-chuang@nih.gov no later than the date specified on the notice posted to the governmentwide point of entry (GPE). Quotations submitted via any other method (e.g. facsimile, postal mail) will not be considered. Modifications, quotes, or revisions received after the deadline posted in the RFQ will be considered “late” and will not be accepted by the Government, except in accordance with the requirements at FAR 52.212-1(f). Quotes should be in MS Office (e.g. Word, Excel), or Adobe PDF format. Please reference the RFQ number 75N91021Q00228 in all correspondence. BUSINESS CREDENTIALS Quoters shall prepare a quote which includes the following administrative/business information: Federal Tax Identification Number (TIN); Commercial and Government Entity (CAGE) code; Data Universal Numbering System (DUNS) number; Business size and socioeconomic designation (e.g. small, large, WOSB); and Point-of-contact name and information for individual authorized to commit the contractor. ** Please include a statement to the effect that pricing is firm for a period of at least 60 days from the date of receipt of the Government ** PRICING INFORMATION Quoters shall prepare a price quote in response to this solicitation. The quote must include all information necessary to allow for a comprehensive evaluation for the prices quoted, to include: Unit price, extended price, and discounts applied, if provided. Credits, value, or discounts applied as a result of trade-in. Price for other direct costs including travel, training, and installation if applicable. A total price summary (i.e. sum) of all provided pricing. Quoters must include all shipping, freight, travel and/or other costs necessary for performance of this requirement in their price quote. The NCI will not accept invoices which include items not listed on the Quoter’s initial quote and incorporated into the schedule of items for the resulting purchase order (PO). TRADE-IN The following property is being offered in accordance with the exchange provisions of 40 U.S.C. 503. IncuCyte HD/2CLR system Mfr: Essen Bioscience S/N: 40224 Condition: Good The property is located at: 37 Center Drive Bethesda, MD 20892 SYSTEM FOR AWARD MANAGEMENT Quoters must be registered in the System for Award Management (SAM) and must have completed the relevant representations and certifications to be eligible for award as a result of this RFQ. Quoters who are not registered in SAM or who do not have the required representations and certifications when they submit a quote may be deemed non-responsive and ineligible for award. ** Quoters who are registered in SAM but who have not completed the representations at FAR 52.204-24 and/or FAR 52.204-26 – or any other representations required by this RFQ – must complete those representations and submit them with their quote ** EVALUATION PROCEDURES This request is conducted in accordance with FAR Part 13. A single purchase order (PO) will be awarded to the firm that submits the lowest priced technically acceptable (LPTA) quotation. A technically acceptable quotation is one which the Quoter complies with the Statement of Need (SON) and does not take exception nor object to any of the terms of the RFQ. Quotes which are not technically acceptable will not be considered for award. The technical evaluation will be conducted based on information furnished by the Contractor. The Government is not responsible for locating or securing any information which is not identified in the quotation. The Government intends to evaluate quotations and make an award without conducting “discussions.” Therefore, the Quoter’s initial quote should contain the best terms from a price and technical standpoint. The Government will evaluate price reasonableness based on the total evaluated price (TEP). The TEP shall be the sum price of all contract line items (including any shipping fees or other costs), less any discounts or “credits” provided as a result of any trade-in equipment. The TEP will be used to determine the “lowest-priced” quote for evaluation purposes. The Government may request additional non-certified price information if the information contained in the quote is insufficient to make a price reasonableness determination. The Government may also elect to evaluate the price reasonableness or price realism of any individual line item. If pricing is found to be unrealistic or unbalanced in any one CLIN, the entire price may be evaluated as “unreasonable” or “unrealistic.”